SCHEMBL31469077

SCHEMBL31469077

Oc1cccc(Nc2nc(Cl)nc3c2SCC3)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 7/20 0.41
▸ PIM1 P11309 3/20 0.41
▸ EGFR P00533 2/20 0.41
▸ DYRK3 O43781 1/20 0.41
▸ PRKD3 O94806 1/20 0.41
▸ MAP4K4 O95819 1/20 0.41
▸ CDK1 P06493 1/20 0.41
▸ RET P07949 1/20 0.41
▸ PRKACA P17612 1/20 0.41
▸ FLT4 P35916 1/20 0.41
▸ FRK P42685 1/20 0.41
▸ CSNK1D P48730 1/20 0.41
▸ CLK2 P49760 1/20 0.41
▸ GSK3A P49840 1/20 0.41
▸ GSK3B P49841 1/20 0.41
▸ IRAK1 P51617 1/20 0.41
▸ NEK4 P51957 1/20 0.41
▸ CSNK2A1 P68400 1/20 0.41
▸ CDK5 Q00535 1/20 0.41
▸ PRKCZ Q05513 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19624259 0.85 NFKB1 (0.51) EGFRCDK1CDK5MAPTRAB9A
SCHEMBL375687 0.85 PDE4B (0.44) EGFRCSNK2A1MAPTRAB9AKMT2A
SCHEMBL3938216 0.83 RHOA (0.46) EGFRCSNK2A1MAPTRAB9AMEN1
SCHEMBL13211477 0.82 HPGD (0.46) MAPTRAB9AALOX5MEN1KMT2A
SCHEMBL31083985 0.81 MAPK1 (0.49) MAPTRAB9AMEN1KMT2ACYP3A4
SCHEMBL658170 0.76 CYP3A4 (0.52) SYKPIM1EGFRDYRK3PRKD3
SCHEMBL3517759 0.76 CCNT1 (0.49) CDK1CSNK2A1IRAK4TSHR
SCHEMBL31469083 0.76 PDE4B (0.47) —
SCHEMBL589243 0.75 PLK4 (0.44) EGFRCDK1SMN1; SMN2
SCHEMBL31491328 0.75 KIF11 (0.41) SYKMAPTRAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119684313-A Macrocyclic compound and preparation method and application thereof 上海爱科百发生物医药技术股份有限公司 2025-03-25 — — CN disclosed
Send feedback